Nitroprusside stimulates contractility and the synthesis of 14C- acetylated PAF-like substances in estrogen primed-mouse uterine horns

Prostaglandins and Other Lipid Mediators

Volumn 57, Issue 1, 1999, Pages 49-62

  Martinez L ^a   Gimeno, M F ^b   Villan L ^a   Villar, M ^a   Rudolph, M I ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Estrogen; Nitric oxide; Platelet activating factor (PAF); Sodium nitropruside; Uterus

Indexed keywords

CROMOGLYCATE DISODIUM; ESTROGEN; HEMOGLOBIN; HISTAMINE; INDOMETACIN; KETANSERIN; KETOTIFEN; MEPYRAMINE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PEROXYNITRITE; RITODRINE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; HISTAMINE RELEASE; HORMONAL REGULATION; ISOLATED ORGAN; MAST CELL; MOUSE; NONHUMAN; UTERUS CONTRACTILITY; UTERUS HORN;

ANIMALS; CARBON RADIOISOTOPES; ESTROGENS; FEMALE; HISTAMINE RELEASE; MICE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PLATELET ACTIVATING FACTOR; UTERINE CONTRACTION; UTERUS;

EID: 0344759150     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(98)00071-9     Document Type: Article

References (46)

1. Bates J.N., Baker M.T., Guerra R., Harrison D.G. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside and cyanide loss are required. Biochem Pharmacol. 42:(suppl):1991;5157-5165.
2. Yallampalli C., Izumi H., Byam-Smith M., Garfield R. An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol. 170:1993;175-185.
3. Franchi A.M., Chaud M., Rettori V., Suburo A., McCann S.M., Gimeno M.A.F. Role of nitric oxide in eicosanoid synthesis and uterine motility in estrogen-treated rat uteri. Proc Natl Acad Sci USA. 91:1994;539-543.
4. Motta AB, Gonzalez ET, Rudolph MI, Gimeno MAF. Nitric oxide production by rat myometrial cells. Influence on PGE synthesis. Prostaglandins Leukot Essent Fatty Acids (in press).
5. Lapetina E.G. Regulation of arachidonic acid production role of phospholipase C and A2 . Trends Pharmacol Sci. 3:1982;115-118.
6. Bany B.M., Kennedy T.G. Interleukin-1α regulates prostaglandin production and cyclooxygenase activity in sensitized rat endometrial stromal cells in vitro. Biol Reprod. 53:1995;126-132.
7. Okazaki T., Sagawa N., Bleasdale J.E., Okita J.R., MacDonald P.C., Johnston J.M. Initiation of human parturition. XIII. Phospholipase C, phospholipase A2, and diacylglycerol lipases activities in fetal membranes and decidua vera tissues from early and late gestation. Biol Reprod. 25:1981;103-112.
8. Alecozay A.A., Casslén B.G., Rielhl R.M., et al. Platelet-activating factor in human luteal phase endometrium. Biol Reprod. 41:1989;578-586.
9. 2α by the uterus in situ. Biol Reprod. 54:1996;355-363.
10. Uemura Y., Lee T., Snyder F. A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodelling pathway. J Biol Chem. 266:1996;8268-8272.
11. Snyder F. Platelet activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol. 259:(Cell Physiol 28):1990;C697-C708.
12. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needeleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA. 90:1996;7240-7244.
13. Montesino H., Villar M., Vega E., Rudolph M.I. Histamine, a neuromodulator of noradrenergic transmission in uterine horns from mice in diestrus. Biochem Pharmacol. 50:1995;407-411.
14. Folch J., Lees M., Sloane-Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 226:1956;497-510.
15. Angle M.J., Jones M.A., McManus L.M., Pinckard R.N., Harper M.J.K. Platelet-activating factor in the rabbit uterus during early pregnancy. Reprod Fert. 83:1988;711-722.
16. Billah M.M., Johnston J.M. Identification of phospholipid platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in amniotic fluid and urine. Biochem Biophys Res Commun. 131:1983;51-58.
17. Rudolph M.I., Bardisa L., Cruz M.A., Reinicke K. Mast cells mediators evoke contractility and potentiate each other in mouse uterine horns. Gen Pharmacol. 23:1992;833-836.
18. Rudolph M.I., Cabanilllas A., Gomez P., Garcia M.A., Villan L. On the mechanism of action of ethodin in inducing myometrium contractions. Gen Pharmacol. 28:1997;381-385.
19. Yamatodani A., Fukuda H., Wada H., Iwaeda T., Watanabe T. High performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples cation-exchange derivatization fluorometry . J Chromatogr. 344:1985;115-123.
20. Casals-Stenzel J., Muacevic G., Weber K. Pharmacological actions of WEB 2086, a new specific antagonist of platelet-activating factor. J Pharmacol Exp Ther. 241:1987;974-981.
21. Rudolph M.I., Garcia M.A., Sepulveda M., et al. Ethodin pharmacological evidence of the interaction between smooth muscle and mast cells in the myometrium . J Pharmacol Exp Ther. 282:1997;256-261.
22. Albisugun A.O., Braquet P., Tsafriri A. The involvement of platelet activating factor in ovulation. Science. 240:1989;381-383.
23. Ricker D.D., Minhas B.S., Kumar R., Robertson J.L., Dodson M.G. The effects of platelet-activating factor on the motility of human spermatozoa. Fertil Steril. 52:1989;655-656.
24. Ryan J.P., Spinks N.R., O'Neill C., Wales R.G. Implantation potential and fetal viability of mouse embryos cultured in media supplemented with platelet-activating factor. J Reprod Fert. 89:1990;309-315.
25. Angle M.J., Jonhston J.M. Fetal tissues in autacoid biosynthesis in relation to the initiation of parturition and implantation. Carsten M., Miller J.D. Uterine Function Molecular and Cellular Aspects . 1990;471-485 Plenum Press, New York.
26. Matsubara T., Yasuda K., Johnston J.M., et al. Platelet-activating factor (PAF) and PAF Acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy. Biol Reprod. 56:1997;885-890.
27. Roukin R., Tense M., Mencia-Huerta J.M., Arnous B., Ninio E., Benveniste J. A chemically defined monokine macrophague-derived platelet-activating factor (PAF-acether) . Lymphokines. 8:1983;240-248.
28. Baldi E., Bonaccorsi L., Finetti G., et al. Platelet-activating factor in human endometrium. J Steroid Biochem Mol Biol. 49:1994;359-363.
29. Zanglis A., Lianos E.A., Demopoulos C.A. The biological activity of acetylated sphingosylphosphorylcholine derivatives. Int J Biochem Cell Biol. 28:1996;63-74.
30. Lynch J.M., Henson P.M. The intracellular retention of newly synthesized platelet-activating factor. J Immunol. 137:1986;2653-2661.
31. Bussolino F., Camussi G. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur J Biochem. 229:1995;327-337.
32. Zhu Y.-P., Word A., Johnston J.M. The presence of platelet-activating factor binding sites in human myometrium anf their role in uterine contraction. Am J Obstet Gynecol. 166:1992;1222-1228.
33. Johns R.A. Endothelium-derived relaxing factor basic review and clinical implications . J Cardiothorac Vasc Anesth. 5:1991;69-79.
34. Mayer B., Brunner F., Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol. 45:1993;367-374.
35. Furchgott R.F., Khan M.T., Jothianandan D. Comparison of properties of nitric oxide and endothelium-derived relaxing factor some cautionary findings . Rubanyi G.M., Vandehoutte P.M. Endothelium-Derived Relaxing Factors. 1990;8-21 Karger, Basel, Switzerland.
36. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun. 18:1993;195-199.
37. Riley J.C.M., Behrman H.R. Oxygen radicals and reactive oxygen species in reproduction. Proc Soc Exp Biol Med. 198:1991;781-791.
38. 2 in the secretory granule. Biochem J. 300:1994;619-622.
39. 2 in the secretory granule of the mast cell. J Histochem Cytochem. 37:1989;1319-1328.
40. Massey W.A., Guo C.B., Dvorak A.M., et al. Human uterine mast cells isolation, purification, characterization, ultrastructure and pharmacology . J Immunol. 147:1991;1622-1627.
41. Wolfreys K., Oliveira D.B.G. Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur J Immunol. 27:1997;297-306.
42. Monterlini R, Foresti R, Marcos Y, Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidateive stress to endothelium. Am J Physiol 1996;270:(Heart Cir. Physiol 39):H107-H114.
43. Niu X.-F., Ibbotson G., Kubes P. A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. Circ Res. 79:1996;992-999.
44. Chao T.-C., Phuangsab A., Van Alten P.J., Walter R.J. Steroid sex hormones and macrophage function regulation of chemiluminescence and phagocytocis . Am J Reprod Immunol. 35:1996;106-113.
45. Lizasoain I., Moro M.A., Knowles R.G., Darley-Usmar V., Moncada S. Nitric oxide and peroynitrite exert distinct effects on mitochondrial respiration which are differentilly blocked by glutathione or glucose. Biochem J. 314:1996;877-880.
46. Hannon J., Pfannkuche H., Fozard J. A role for mast cells in adenosine A3 receptor mediated hypotention in the rat. Br J Pharmacol. 115:1995;945-952.